GET IN TOUCH
BEGIN TO HEAL
Don’t suffer in silence. Take the first step towards healing and contact us today to discuss treatment options that can help you lead a happier, more fulfilling life.
Menu
TMS uses non- invasive MRI technology to treat depression! Approximately 50-60% of patients report significant relief of their depressive symptoms, whereas around 30-40% of people report complete resolution of their depression.
If you have tried 2-4 medications with little or no results or adverse side effects, TMS will likely be be a great treatment for you and be covered by insurance.
TMS has also shown excellent results for anxiety, OCD and PTSD. Insurance coverage can be applied for but is not always granted for these off label treatments.
SPRAVATO® (esketamine) CIII nasal spray is a non-selective, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor – an ionotropic glutamate receptor. It is a first-of-its kind medicine approved by the FDA in two major depressive disorder (MDD) subpopulations with high unmet need.
SPRAVATO® is approved in the United States, in conjunction with an oral antidepressant to treat adults with treatment-resistant depression (TRD) and to treat depressive symptoms in adults with MDD with acute suicidal ideation or behavior.
Treatment for a variety of mental health conditions often involves the use of medications. The correct treatment can greatly enhance a patient’s quality of life by reducing or eliminating symptoms.
But mental health specialists are well aware that each patient responds to medicine differently. Skilled experts are aware of how to take into consideration a variety of variables, including medical history and drug regimen.
Electroconvulsive therapy (ECT), casually referred to as electric shock therapy, is a treatment for severe episodes of psychiatric disorders, especially major depression, mania, PTSD and some types of schizophrenia. It involves the use of a brief, controlled electrical current to produce a seizure within the brain. This seizure activity is thought to target neurotransmitters involved with mental illness in an effort to bring about certain biochemical changes in the brain. It is administered in a series of treatments, between 6 to 12 treatments, given three times a week to reach a therapeutic benefit.
Fill out the form below and we will contact you as soon as possible!